Sunday, April 18, 2021 10:00:15 AM
Another factor is Cost of new patients. Ad cost were exceptionally high in Q4 due to the presidential election. Costs will be in line now AND the exceptional level of subscription relationships will mean a decline in the average marketing cost per shipment. Hence when Q1 comes out, expenses will look much more moderate.
Predicting the stock price is difficult due to the short situation. Will they continue to try to suppress? Will they scramble to cover in the face of high investor demand for a cheap stock? Will more institutions buy a bargain? But the trend will be up. This week's revenue announcement could be pivotal. If revenue growth accelerated from Q4 we may be off to the races.
Recent LFMD News
- LifeMD Becomes the First Virtual Primary Care Provider to Elevate GLP-1 Patient Care with Real-time, At-Home Monitoring of Blood Pressure and Body Composition • GlobeNewswire Inc. • 05/02/2024 12:00:00 PM
- LifeMD Appoints Dr. Calum MacRae to its Board of Directors • GlobeNewswire Inc. • 04/29/2024 12:00:00 PM
- LifeMD to Report First Quarter 2024 Financial Results on May 8 • GlobeNewswire Inc. • 04/24/2024 12:00:00 PM
- LifeMD to Participate in Upcoming Investor and Industry Conferences During May • GlobeNewswire Inc. • 04/23/2024 12:00:00 PM
- LifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock • GlobeNewswire Inc. • 03/26/2024 12:00:00 PM
- LifeMD to Participate in the 23rd Annual Needham Virtual Healthcare Conference • GlobeNewswire Inc. • 03/25/2024 12:00:00 PM
- LifeMD Reports Fourth Quarter 2023 Results • GlobeNewswire Inc. • 03/11/2024 08:05:00 PM
- U.S. Index Futures Dip Ahead of Inflation Data and Oracle’s Earnings; Oil Prices Edge Higher • IH Market News • 03/11/2024 10:39:47 AM
- LifeMD to Report Fourth Quarter 2023 Financial Results on March 11 • GlobeNewswire Inc. • 02/26/2024 01:00:00 PM
- LifeMD to Participate in Upcoming Investor Conferences and Webinar • GlobeNewswire Inc. • 02/15/2024 01:00:00 PM
- LifeMD to Participate in the 11th Annual BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference • GlobeNewswire Inc. • 01/31/2024 01:00:00 PM
- Maxim Group LLC to Host the 2024 Healthcare IT Virtual Conference on Wednesday, January 24th & Thursday, January 25th at 9:00 A.M. ET • GlobeNewswire Inc. • 01/22/2024 09:15:00 PM
- LifeMD to Participate in the Maxim Group 2024 Healthcare IT Virtual Conference • GlobeNewswire Inc. • 01/18/2024 01:00:00 PM
- LifeMD Provides 2024 Financial Guidance • GlobeNewswire Inc. • 01/08/2024 01:00:00 PM
- WeightWatchers Stock Drops 12% After Eli Lilly Launches DTC Weight-Loss Drug Service • Dow Jones News • 01/04/2024 09:30:00 PM
- LifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock • GlobeNewswire Inc. • 12/26/2023 09:05:00 PM
- LifeMD and Medifast Partner to Offer Transformative Weight Management Solution • GlobeNewswire Inc. • 12/13/2023 11:00:00 AM
- LifeMD Executives to Participate in RWJBarnabas Health’s Telehealth Symposium • GlobeNewswire Inc. • 12/07/2023 01:00:00 PM
- LifeMD to Participate in Upcoming Investor Conferences and Panel Discussions • GlobeNewswire Inc. • 11/10/2023 01:00:00 PM
- LifeMD Reports Third Quarter 2023 Results; Record Revenue and Adjusted EBITDA • GlobeNewswire Inc. • 11/08/2023 09:05:00 PM
- LifeMD Ranked Number 166 Fastest-Growing Company in North America on the 2023 Deloitte Technology Fast 500™ • GlobeNewswire Inc. • 11/08/2023 01:00:00 PM
- LifeMD to Report Third Quarter 2023 Financial Results on November 8 • GlobeNewswire Inc. • 10/25/2023 12:00:00 PM
- Particle Health and LifeMD Demonstrate the Potential of Using Comprehensive Electronic Health Record Data to Triage Patients for GLP-1 Weight Management Therapy • GlobeNewswire Inc. • 10/03/2023 10:00:00 AM
- LifeMD to Participate in Two Investor Conferences in October • GlobeNewswire Inc. • 09/27/2023 12:00:00 PM
- LifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock • GlobeNewswire Inc. • 09/26/2023 12:00:00 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM